These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38245917)

  • 1. Social influence in the darknet market: The impact of product descriptions on cocaine sales.
    Andrei F; Veltri GA
    Int J Drug Policy; 2024 Feb; 124():104328. PubMed ID: 38245917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing market competition and vendors' size and scope on AlphaBay.
    Paquet-Clouston M; Décary-Hétu D; Morselli C
    Int J Drug Policy; 2018 Apr; 54():87-98. PubMed ID: 29414490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data.
    Rhumorbarbe D; Staehli L; Broséus J; Rossy Q; Esseiva P
    Forensic Sci Int; 2016 Oct; 267():173-182. PubMed ID: 27611957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Televend, an innovative combination of cryptomarket and messaging app technologies for trading prohibited drugs.
    Barratt MJ; Lamy FR; Engel L; Davies E; Puljevic C; Ferris JA; Winstock AR
    Drug Alcohol Depend; 2022 Feb; 231():109243. PubMed ID: 34999269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding hidden darknet networks: What we learned about the illicit fentanyl trade on AlphaBay.
    Maras MH; Logie K; Arsovska J; Wandt AS; Barthuly B
    J Forensic Sci; 2023 Sep; 68(5):1451-1469. PubMed ID: 37515466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital figurations in the online trade of illicit drugs: A qualitative content analysis of darknet forums.
    Kamphausen G; Werse B
    Int J Drug Policy; 2019 Nov; 73():281-287. PubMed ID: 31054881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carfentanil on the darknet: Potential scam or alarming public health threat?
    Negri A; Townshend H; McSweeney T; Angelopoulou O; Banayoti H; Prilutskaya M; Bowden-Jones O; Corazza O
    Int J Drug Policy; 2021 May; 91():103118. PubMed ID: 33482605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis.
    Cunliffe J; Décary-Hêtu D; Pollak TA
    Int J Drug Policy; 2019 Nov; 73():263-272. PubMed ID: 30772109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranking Trust Factors Affecting Risk Perception in Illicit Drug Purchase on the Darknet: A Large-Scale Survey Study in Hungary.
    Kiss T; Szigeti Á
    Eur J Crim Pol Res; 2023 May; ():1-16. PubMed ID: 37361419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge.
    Bancroft A; Scott Reid P
    Int J Drug Policy; 2016 Sep; 35():42-9. PubMed ID: 26777135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the Event Analysis of Systemic Teamwork (EAST) broken-links approach to understand vulnerabilities to disruption in a darknet market.
    Lane BR; Salmon PM; Cherney A; Lacey D; Stanton NA
    Ergonomics; 2019 Sep; 62(9):1134-1149. PubMed ID: 31117925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets.
    Norbutas L; Ruiter S; Corten R
    Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis.
    Martin J; Cunliffe J; Décary-Hétu D; Aldridge J
    BMJ; 2018 Jun; 361():k2270. PubMed ID: 29899119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the structure and operation of drug supply chains: The case of cocaine and heroin in Italy and Slovenia.
    Caulkins JP; Disley E; Tzvetkova M; Pardal M; Shah H; Zhang X
    Int J Drug Policy; 2016 May; 31():64-73. PubMed ID: 26997542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sellers' risk perceptions in public and private social media drug markets.
    Bakken SA; Demant JJ
    Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterising the online weapons trafficking on cryptomarkets.
    Rhumorbarbe D; Werner D; Gilliéron Q; Staehli L; Broséus J; Rossy Q
    Forensic Sci Int; 2018 Feb; 283():16-20. PubMed ID: 29245040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange.
    Sawicka M; Rafanell I; Bancroft A
    Int J Drug Policy; 2022 Feb; 100():103514. PubMed ID: 34768125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.